Cargando…
A potent human neutralizing antibody Fc-dependently reduces established HBV infections
Hepatitis B virus (HBV) infection is a major global health problem. Currently-available therapies are ineffective in curing chronic HBV infection. HBV and its satellite hepatitis D virus (HDV) infect hepatocytes via binding of the preS1 domain of its large envelope protein to sodium taurocholate cot...
Autores principales: | Li, Dan, He, Wenhui, Liu, Ximing, Zheng, Sanduo, Qi, Yonghe, Li, Huiyu, Mao, Fengfeng, Liu, Juan, Sun, Yinyan, Pan, Lijing, Du, Kaixin, Ye, Keqiong, Li, Wenhui, Sui, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614562/ https://www.ncbi.nlm.nih.gov/pubmed/28949917 http://dx.doi.org/10.7554/eLife.26738 |
Ejemplares similares
-
Novel Abs targeting the N‐terminus of fibroblast growth factor 19 inhibit hepatocellular carcinoma growth without bile‐acid‐related side‐effects
por: Liu, Huisi, et al.
Publicado: (2020) -
Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide
por: He, Wenhui, et al.
Publicado: (2015) -
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants
por: Zhang, Jing, et al.
Publicado: (2022) -
FcγRIIB-I232T polymorphic change allosterically suppresses ligand binding
por: Hu, Wei, et al.
Publicado: (2019) -
A pH-dependent anti-CD47 antibody that selectively targets solid tumors and improves therapeutic efficacy and safety
por: Li, Yulu, et al.
Publicado: (2023)